Astellas Pharma is a pharmaceutical company focusing on the research, development, and commercialization of innovative medicines. With a diverse and dedicated workforce, the company's mission is to improve the health of people globally through innovative drug therapies.
Founded in 2005 through the merger of Yamanouchi Pharmaceutical Co., Astellas Pharma has grown into a multinational corporation with headquarters in Japan and operations in Illinois. The company employs over 17,000 people and generates an annual revenue of $11.1 billion. Some notable brands and products associated with Astellas Pharma include Novartis, Boehringer Ingelheim, and Allergan plc. Under the leadership of CEO Matthew Roberts, Astellas continues to pave the way for advancements in the pharmaceutical industry.